Cetera Investment Advisers Organogenesis Holdings Inc. Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 60,768 shares of ORGO stock, worth $275,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,768Holding current value
$275,279% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ORGO
# of Institutions
125Shares Held
71.6MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.3MShares$55.9 Million3.5% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN6.78MShares$30.7 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...